1. Linear IgA Bullous Dermatosis: A Retrospective Study of 23 Patients in Denmark
- Author
-
Anette Bygum and Kristina Lings
- Subjects
Glucocorticoids/therapeutic use ,Male ,Denmark ,Anti-Infective Agents/therapeutic use ,Prednisone/therapeutic use ,Dapsone ,Naranjo algorithm ,Anti-Infective Agents ,Sulfapyridine ,Autoimmune disease ,Age of Onset ,Young adult ,Incidence ,Incidence (epidemiology) ,General Medicine ,Middle Aged ,Linear IgA Bullous Dermatosis ,Linear IgA Bullous Dermatosis/drug therapy ,Child, Preschool ,Bullous disease ,Female ,IgA ,medicine.drug ,Adult ,medicine.medical_specialty ,Dapsone/therapeutic use ,Linear IgA bullous dermatosis ,Dermatology ,Young Adult ,Age groups ,medicine ,Humans ,Glucocorticoids ,Aged ,Retrospective Studies ,business.industry ,Infant ,Retrospective cohort study ,Sulfapyridine/therapeutic use ,medicine.disease ,Denmark/epidemiology ,Surgery ,Treatment ,Prednisone ,Chronic bullous disease of childhood ,Age of onset ,business - Abstract
Linear IgA bullous dermatosis (LAD) is an autoimmune, chronic bullous disease affecting primarily young children and adults. Studies on LAD are relatively sparse and from Scandinavia we could only find a few case reports. Therefore we decided to conduct a retrospective investigation of patients seen at our department since 1972. A total of 23 patients were identified; 7 children (F:M ratio 0.75) and 16 adults (F:M ratio 0.78). Mean age at disease onset in the two age groups were 2.7 and 56.8 years. Estimated incidence rate in our region: 0.67 per million per year. The most commonly used treatment modalities were corticosteroids, dapsone and sulphapyridine.
- Published
- 2015
- Full Text
- View/download PDF